论文部分内容阅读
我院1997-02~2005-12采用异环磷酰胺(IFO)、吡喃阿霉素(THP)联合甲基强的松龙治疗难治性急性淋巴细胞白血病(ALL)16例,疗效较好,现分析如下。1临床资料1.1一般资料本组诊断参照2004年第4届全国难治性白血病会研讨会制定的标准[1]。男11例,女5例,年龄3~67岁,中位年龄31.5岁。L13
In our hospital from February 1997 to December 2005, 16 patients with refractory acute lymphoblastic leukemia (ALL) were treated with ifosfamide (IFO), pirarubicin (THP) and methylprednisolone Now analysis is as follows. 1 Clinical data 1.1 General Information The diagnosis of reference to the 2004 Fourth National Conference on Refractory Leukemia standards [1]. There were 11 males and 5 females, aged 3 to 67 years, with a median age of 31.5 years. L13